Drug trial offers new hope for untreatable brain malformations
NCT ID NCT06264531
Summary
This study is testing if a drug called bevacizumab, given through an IV, can help improve symptoms like headaches, seizures, thinking problems, or weakness in adults with complex brain arteriovenous malformations (AVMs). It is for people whose AVMs cause significant symptoms and who are not eligible for standard surgeries or procedures. The main goal is to see if the treatment safely reduces the burden of these disabling symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL AV MALFORMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HFAR
RECRUITINGParis, Île-de-France Region, 75019, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.